Ovarian Cyst Rupture
Ruptured ovarian cysts are a common gynecological emergency presentation, most frequently involving functional (physiological) cysts, particularly the corpus luteum. The condition is generally self-limiting, with approximately 80–85% of cases managed conservatively; surgery is required in ~15–20% of cases, primarily for hemodynamic compromise or large hemoperitoneum. [1-2]
History
- Onset: Sudden-onset, sharp, unilateral lower abdominal/pelvic pain — often described as a "pop" or acute tearing sensation
- Timing: Frequently occurs mid-cycle (follicular cyst) or in the luteal phase (corpus luteum); may follow sexual intercourse, exercise, or straining, though no consistent trigger is identified [1]
- Severity: Ranges from mild discomfort to severe, incapacitating pain
- Associated symptoms: Nausea, vomiting, vaginal bleeding, lightheadedness/presyncope (if significant hemorrhage)
- Important negatives to elicit: Fever (argues against simple rupture), missed period or pregnancy possibility, history of IUD/contraception use, prior STI history, urinary symptoms, bowel changes
- Menstrual history: Last menstrual period, regularity, possibility of pregnancy [3]
Alarm Features
- Hemodynamic instability: Tachycardia, hypotension (SBP <90 mmHg), diastolic BP ≤70 mmHg — strongly predicts need for surgical intervention [2]
- Peritoneal signs: Diffuse rebound tenderness, guarding, rigidity
- Syncope or presyncope with acute pelvic pain
- Positive pregnancy test — must rule out ruptured ectopic pregnancy, which can cause fatal hemoperitoneum [4]
- Signs of hemorrhagic shock: Pallor, diaphoresis, altered mental status, tachypnea [5]
- Persistent or worsening pain despite analgesia
- Fever >38°C — raises concern for tubo-ovarian abscess or other infectious etiology [3]
Medications
- Relevant contributors:
- Acute treatment:
- NSAIDs (ketorolac 15–30 mg IV, ibuprofen 600–800 mg PO) — first-line analgesia
- Opioids (morphine, fentanyl) for severe pain refractory to NSAIDs
- IV fluids for volume resuscitation if hemodynamically compromised
- Antiemetics (ondansetron) as needed
- Prevention of recurrence:
- Combined oral contraceptives (COCs) suppress ovulation and prevent recurrent functional cyst rupture [10]
- In patients on anticoagulation, progestin-only methods (subdermal implant preferred, or depo-medroxyprogesterone, LNG-IUD) are first-line for ovulation suppression to prevent hemorrhagic cysts [6]
- Contraindicated: Avoid aspirin/NSAIDs in patients with active hemorrhage and hemodynamic instability; hold anticoagulants in acute hemorrhagic rupture [11]
Diet
- No specific dietary triggers for ovarian cyst rupture
- NPO status if surgical intervention is anticipated
- Adequate hydration during conservative management
- Long-term: No evidence-based dietary modifications to prevent recurrence
Review of Systems
- GI: Nausea, vomiting, anorexia, change in bowel habits (constipation/diarrhea may mimic GI pathology)
- GU: Dysuria, urinary frequency/urgency (to rule out UTI/nephrolithiasis), vaginal bleeding or discharge
- Reproductive: Missed period, dyspareunia, prior ovarian cyst history
- Constitutional: Fever, chills (infectious etiology), weight loss, bloating (malignancy)
- Cardiovascular: Lightheadedness, syncope, palpitations (hemorrhage)
Collateral History and Family History
- Collateral: Confirm timing of symptom onset, any witnessed syncope, medication compliance (especially anticoagulants)
- Family history:
- Ovarian or breast cancer (BRCA mutations) — relevant if complex cyst morphology raises malignancy concern [3]
- Bleeding disorders — von Willebrand disease is associated with a 52% incidence of ovarian cysts vs. 22% in controls [12]
- Endometriosis (endometrioma rupture)
- Social context: Sexual activity, contraception use, STI risk factors
Risk Factors
- Reproductive age — peak incidence in women 15–45 years
- Anticoagulation therapy — well-documented risk for hemorrhagic cyst rupture with significant hemoperitoneum [6-7][13]
- Bleeding disorders (von Willebrand disease, platelet dysfunction) [12]
- Ovulation induction/fertility treatments [9]
- Prior ovarian cyst or rupture history
- Corpus luteum cyst (more vascular than follicular cysts, higher hemorrhage risk) [14]
- Right ovary — most ruptures occur on the right, possibly due to proximity to the appendix and differences in venous drainage [14]
- Pregnancy — increases risk of corpus luteum rupture [14]
- No consistent association with sexual intercourse or trauma as triggers [1]
Differential Diagnosis
- Cannot-miss diagnoses:
- Other important differentials:
- Tubo-ovarian abscess — fever, vaginal discharge, cervical motion tenderness [3]
- Endometrioma rupture — history of endometriosis, "chocolate cyst" contents, chemical peritonitis
- Ruptured dermoid cyst — elevated CRP, CA-125, CA 19-9, SCC; risk of chemical peritonitis [18]
- Nephrolithiasis — flank pain radiating to groin, hematuria
- Pelvic inflammatory disease — bilateral pain, discharge, fever
- Ovarian hyperstimulation syndrome — in patients on fertility medications [9]
- Mesenteric ischemia, bowel obstruction (in older patients)
Past Medical History
- Prior ovarian cysts, ruptures, or ovarian surgery
- Endometriosis
- Bleeding disorders or anticoagulant use
- History of ectopic pregnancy
- Pelvic inflammatory disease or STIs
- Fertility treatments
- Cardiac conditions requiring anticoagulation (mechanical valves, atrial fibrillation) [13]
Physical Exam
- Vital signs: Tachycardia (often the first sign of hemorrhage), hypotension, orthostatic changes [5][11]
- Abdominal exam: Unilateral lower quadrant tenderness (may be bilateral if significant free fluid), guarding, rebound tenderness, rigidity
- Pelvic exam:
- Adnexal tenderness (unilateral)
- Cervical motion tenderness (also seen in ectopic pregnancy, PID, torsion — not specific)
- Assess for vaginal bleeding
- Palpable adnexal mass (may or may not be present)
- Concerning findings: Diffuse peritonitis, distended abdomen, pallor, diaphoresis, cool extremities
Lab Studies
- β-hCG (urine or serum) — mandatory in all reproductive-age women to rule out ectopic pregnancy [4]
- CBC — hemoglobin/hematocrit to assess degree of hemorrhage; initial Hgb was significantly lower in surgical vs. conservative groups (11.3 vs. 12.2 g/dL); serial monitoring recommended [19]
- Type and screen/crossmatch — if significant hemorrhage suspected
- Coagulation studies (PT/INR, aPTT) — especially in patients on anticoagulants [8]
- BMP — assess renal function, electrolytes
- Lactate — if concern for hemorrhagic shock or tissue hypoperfusion [5]
- Urinalysis — rule out UTI/nephrolithiasis
- CA-125 — not routinely needed acutely; consider if complex cyst morphology or postmenopausal patient raises malignancy concern [20]
Imaging
- First-line: Transvaginal ultrasound (TVUS) combined with transabdominal ultrasound — imaging modality of choice per ACR Appropriateness Criteria [21-22]
- Sensitivity of 88.2% for hemorrhagic cysts [21]
- Findings: Collapsed or irregular cyst wall, echogenic free fluid (hemoperitoneum), "ring of fire" sign on Doppler (hypervascularity of cyst wall), retracted clot
- Quantify free fluid: Posterior cul-de-sac fluid depth, presence of fluid in Morrison's pouch or paracolic gutters
- CT abdomen/pelvis with IV contrast:
- Not first-line for suspected gynecologic etiology [21]
- Useful when diagnosis uncertain, US inconclusive, or concern for non-gynecologic pathology
- Findings: Irregularly enhancing adnexal cyst with hemorrhagic free fluid, sentinel clot sign, active contrast extravasation [21][23]
- Hemoperitoneum depth >5.8 cm and active bleeding on CT are significant predictors of surgical intervention (OR 5.786 when both present) [23]
- Presence of liver-dome fluid on imaging predicts need for surgery [19]
- MRI: Reserved for indeterminate cases; 100% sensitivity for hemorrhagic cysts [21]
- Imaging unnecessary: Small, simple cysts in asymptomatic patients with known functional cyst history
Special Tests
- FAST exam (bedside ultrasound): Rapid identification of free fluid in the pelvis and abdomen; expedites triage in the ED [5][24]
- Culdocentesis: Historically used to confirm hemoperitoneum (positive if hematocrit >12% suggests surgical hemorrhage); largely replaced by ultrasound [14]
- Shock Index (HR/SBP): >1.0 suggests significant hemorrhage requiring aggressive resuscitation
- Predictors of surgical need: [2][19][23]
- Diastolic BP ≤70 mmHg
- Pelvic fluid depth ≥5.6 cm on CT
- Active contrast extravasation
- Liver-dome fluid on imaging
- Initial Hgb <11 g/dL
ECG
- Not routinely indicated for uncomplicated ovarian cyst rupture
- Obtain ECG if:
- Hemodynamically unstable (to evaluate for demand ischemia, arrhythmia)
- Significant hemorrhage with tachycardia
- Older patients or those with cardiac comorbidities
- Expected findings in hemorrhagic shock: Sinus tachycardia; ST changes may indicate demand ischemia in the setting of anemia/hypovolemia
Assessment
Ruptured ovarian cysts most commonly involve functional cysts (corpus luteum > follicular) in reproductive-age women. [1] The presentation is typically acute unilateral pelvic pain with variable degrees of hemoperitoneum. The condition is self-limiting in ~80–85% of cases. [1-2]
Severity stratification
- Mild: Stable vitals, minimal free fluid, pain controlled → conservative management
- Moderate: Moderate free fluid, borderline vitals, pain requiring IV analgesia → observation with serial exams and labs
- Severe: Hemodynamic instability, large hemoperitoneum, active extravasation → surgical intervention [2][19][23]
Atypical presentations: Right-sided rupture mimicking appendicitis; rupture in pregnancy mimicking ectopic; rupture on anticoagulation presenting with massive hemoperitoneum out of proportion to cyst size [7-8][14]
Complications: Hemorrhagic shock, hemoperitoneum requiring transfusion, chemical peritonitis (dermoid/endometrioma rupture), adhesion formation, recurrence [18]
Treatment Plan
Initial stabilization
- ABCs, two large-bore IVs, cardiac monitoring
- IV crystalloid resuscitation (NS or LR) for hemodynamic instability [11]
- Type and crossmatch; transfuse pRBCs if Hgb <7 g/dL (or <8 g/dL with cardiac disease) [11]
- Hold anticoagulants; consider reversal if life-threatening hemorrhage [11]
Conservative management (majority of cases)
- IV analgesia: Ketorolac 15–30 mg IV, opioids PRN
- Antiemetics: Ondansetron 4 mg IV
- Serial abdominal exams and vital signs q1–4h
- Serial hemoglobin monitoring (q4–6h initially)
- Bed rest, NPO if surgery possible
Surgical intervention (indications)
- Hemodynamic instability despite resuscitation
- Expanding hemoperitoneum on serial imaging
- Diastolic BP ≤70 mmHg + pelvic fluid depth ≥5.6 cm (77.8% surgical rate when both present) [2]
- Active contrast extravasation on CT [23]
- Diagnostic uncertainty (cannot exclude torsion or ectopic)
- Approach: Laparoscopy preferred; cystectomy or ovarian wedge resection with hemostasis; fertility preservation prioritized [1][3]
Recurrence prevention
- Combined oral contraceptives to suppress ovulation [10]
- In patients on anticoagulation: Progestin-only contraception (etonogestrel implant preferred) [6]
- GnRH agonists considered for refractory recurrence in anticoagulated patients [25]
Disposition
- Discharge criteria:
- Hemodynamically stable throughout observation
- Pain controlled with oral medications
- Stable or improving hemoglobin on serial checks
- Minimal free fluid on imaging
- Reliable follow-up arranged
- Negative pregnancy test
- Observation/admission criteria:
- Moderate hemoperitoneum requiring serial monitoring
- Borderline hemodynamics or tachycardia
- Need for IV analgesia
- Patients on anticoagulation (higher risk of ongoing hemorrhage) [26]
- Diagnostic uncertainty
- Surgical/ICU admission:
- Hemodynamic instability
- Need for transfusion
- Active extravasation on imaging
- Failed conservative management
- Specialist consultation triggers:
Follow Up / Return Precautions
- Follow-up timing: OB/GYN follow-up within 1–2 weeks for repeat pelvic ultrasound to confirm resolution
- Repeat imaging: Ultrasound at 6–8 weeks to ensure cyst resolution; persistent complex cysts warrant further evaluation [3-4]
- Return immediately for:
- Increasing or recurrent severe abdominal/pelvic pain
- Lightheadedness, dizziness, or fainting
- Heavy vaginal bleeding
- Fever >38°C
- Nausea/vomiting preventing oral intake
- Feeling of "passing out" or weakness
- Patient counseling:
- Most ruptured cysts resolve without long-term complications
- Functional cysts are common and often recur; discuss contraception for prevention [10]
- Expected recovery: Pain typically improves over 1–3 days; residual soreness may last 1–2 weeks
- Avoid strenuous activity for 1–2 weeks
- If on anticoagulation, discuss ovulation suppression strategies with gynecologist to prevent recurrence [6]
References
1. Trends and Outcomes of Ruptured Ovarian Cysts. — Lim WH, Woods N, Lamaro VP. Postgraduate Medical Journal. 2022.
2. Successful Conservative Management of Ruptured Ovarian Cysts With Hemoperitoneum in Healthy Women. — Kim JH, Lee SM, Lee JH, et al. PloS One. 2014.
3. Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. — Committee on Practice Bulletins—Gynecology Obstetrics and Gynecology. 2016.
4. Lesions of the Ovary and Fallopian Tube. — Sisodia RC, Del Carmen MG. The New England Journal of Medicine. 2022.
5. Hemorrhagic Shock. — Cannon JW. The New England Journal of Medicine. 2018.
6. Special Considerations for Women of Reproductive Age on Anticoagulation. — Azenkot T, Schwarz EB. Journal of General Internal Medicine. 2022.
7. Ovarian Hemorrhage Complicating Warfarin Sodium Anticoagulant Therapy. — Matseoane S, Batts JA, Mandeville EO. American Journal of Obstetrics and Gynecology. 1976.
8. Massive Ovarian Haemorrhage Complicating Oral Anticoagulation in the Antiphospholipid Syndrome: A Report of Three Cases. — Crétel E, Cacoub P, Huong DL, et al. Lupus. 1999.
9. Hemoperitoneum From Ruptured Cyst in a Hyperstimulated Ovary: A Sonographic Mimic of Ovarian Hyperstimulation Syndrome. — Gunabushanam G, Mandal K, Lal S. Journal of Clinical Ultrasound : JCU. 2007.
10. Diagnosis and Management of Ovarian Cyst Accidents. — Bottomley C, Bourne T. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2009.
11. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. — Tomaselli GF, Mahaffey KW, Cuker A, et al. Journal of the American College of Cardiology. 2020.
12. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785. — Committee on Adolescent Health Care Obstetrics and Gynecology. 2019.
13. Ovarian (Corpus Luteum) Hemorrhage During Anticoagulation Therapy. — Tresch DD, Halverson G, Blick M, Keelan MH. Annals of Internal Medicine. 1978.
14. Ruptured Corpus Luteum With Hemoperitoneum: A Study of 173 Surgical Cases. — Hallatt JG, Steele CH, Snyder M. American Journal of Obstetrics and Gynecology. 1984.
15. Does This Woman Have an Ectopic Pregnancy?The Rational Clinical Examination Systematic Review. — Crochet JR, Bastian LA, Chireau MV. The Journal of the American Medical Association. 2013.
16. Adnexal Torsion: Review of Radiologic Appearances. — Dawood MT, Naik M, Bharwani N, et al. Radiographics : A Review Publication of the Radiological Society of North America, Inc. 2021.
17. Acute Abdominal Pain in Adults: Evaluation and Diagnosis. — Yew KS, George MK, Allred HB. American Family Physician. 2023.
18. Clinical Characteristics and Laparoscopic Surgical Outcomes of Ovarian Dermoid Cysts Complicated by Spontaneous Rupture: Nine Cases and a Literature Review. — Takeda A, Koike W. The Journal of International Medical Research. 2023.
19. The Predicting Factors for Indication of Surgery in Patients With Hemoperitoneum Caused by Corpus Luteum Cyst Rupture. — Kim MJ, Kim HM, Seong WJ. Scientific Reports. 2021.
20. Adnexal Masses: Diagnosis and Management. — Wheeler V, Umstead B, Chadwick C. American Family Physician. 2023.
21. ACR Appropriateness Criteria® Acute Pelvic Pain in the Reproductive Age Group: 2023 Update. — Brook OR, Dadour JR, Robbins JB, et al. Journal of the American College of Radiology : JACR. 2024.
22. Evaluation of Acute Pelvic Pain in Women. — Frasca DJ, Jarrio CE, Perdue J. American Family Physician. 2023.
23. Ruptured Corpus Luteal Cyst: Prediction of Clinical Outcomes With CT. — Lee MS, Moon MH, Woo H, et al. Korean Journal of Radiology. 2017.
24. Ultrasound Guidelines: Emergency, Point-of-Care, and Clinical Ultrasound Guidelines in Medicine. — American College of Emergency Physicians (2023). 2023.
25. Management of Peritoneal Hemorrhage Due to Follicle Rupture Under Anticoagulation Therapy. — Ulrich U, Rossmanith WG. Journal of Endocrinological Investigation. 1994.
26. Conservative Management of Corpus Luteum Haemorrhage in Patients on Anticoagulation: A Report of Three Cases and Review of Literature. — Gupta A, Gupta S, Manaktala U, Gupta MM, Solanki V. Archives of Gynecology and Obstetrics. 2015.
More from Deep Dive
Reviewed by Dr. Lucas Mastropaolo. SymptomDx is an educational tool for medical professionals — it does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.